Question 1

Has Nathan Forbush received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $3,570,793 in general payments to Nathan Forbush across 379 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Nathan Forbush did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Nathan Forbush come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Modernatx, Inc.	168	$2,956,046
Seqirus USA Inc	24	$218,127
Sanofi Pasteur Inc.	55	$170,752
AstraZeneca	13	$83,115
Incyte Corporation	10	$73,697
Astrazeneca UK Limited	8	$33,924
Pfizer	35	$33,747
Supernus Pharmaceuticals, Inc.	7	$357
Ironshore Pharmaceuticals Inc.	11	$203
Tris Pharma Inc	10	$169
Merck	6	$116
Cranial Technologies, Inc	5	$94
GSK	5	$80
Neurelis, Inc.	5	$75
Sobi, Inc	3	$55
Collegium Pharmaceutical, Inc.	2	$36
Sanofi-aventis U.S. LLC	2	$35
Takeda Pharmaceuticals U.S.A., Inc.	2	$34
Adlon Therapeutics L.p.	2	$33
Shire North American Group Inc	2	$30
Phadia US Inc.	1	$24
Genentech USA, Inc.	1	$16
Mylan Pharmaceuticals Inc.	1	$16
Corium, LLC	1	$15

Nathan Forbush

Payments from drug & device makers

Who reported the general payments

How this compares

Other pediatrics in Layton